Share this news

No Need to Steer Clear of Electric Cars If You Have a Pacemaker

Landmark study published in Technology and Health Care demonstrates that electric cars do not cause problems for individuals with cardiac implantable electronic device

April 7, 2020
Amsterdam, NL – A study published in Technology and Health Care shows that four leading brands of e-cars do not trigger electromagnetic interference (EMI) with cardiac implantable electronic devices (CIED). CIEDs like pacemakers and defibrillators may malfunction when they are exposed to strong electromagnetic fields (EMF) generated by powerful motors. While rare events, such errors could have serious consequences for patients. With the increasing use of electric-powered vehicles for public and private transport, there is a critical need to assess the potential risks for this population.

Electromagnetic interference is a rare, but potentially catastrophic event for a CIED patient, resulting in pauses or cardiac arrest in pacemaker patients or inappropriate shock delivery in defibrillator patients. CIED patients frequently worry about triggering such events while interacting with appliances such as dishwashers, washing machines, and metal detectors. These concerns are often based on misconceptions and myths exacerbated the limited information available to physicians about the increasing number of electronic and digital devices that emit EMF.

“Our study addresses pressing patient and physician concerns regarding the use of e-cars by patients with CIEDs and we are pleased to report that their use appears safe with current technology. Neither adverse events nor electromagnetic interference were detected while driving or charging the cars during our test,” explained co-investigator Dr. Matthew O’Connor, Department of Electrophysiology, Wellington Hospital, New Zealand.

The investigators attribute the safety of the e-cars tested to the shielding used in electric cars to protect onboard computer systems from EMI. This shielding prevents high EMF levels inside the cars and likely protects CIEDs from interference. The strongest EMF levels were detected during the charging of the vehicles.

One hundred and eight CIED patients drove and charged four commercially available e-cars (Nissan LEAF, Tesla Model S P85, BMW i3, und VW eUp) on a roller-bench test, which simulates road driving in a safe environment. Roller-bench testing provides resistance and maximizes motor output and EMF, which was crucial to ensure simulating real-world EMF generation.

Given the rapidly increasing use of these vehicles for private and public transportation, this study provides important information for patients with CIEDs and is the first to do so using only fully electric cars. Hybrid cars were excluded from the study to control for maximal EMF, since the intermittent use of a combustion engine could result in too much variation in EMF exposure.

“It is important to give evidence-based advice on which devices are dangerous EMI sources and which devices are harmless so that CIED patients can avoid unfounded worries and unnecessary restrictions,” commented lead investigator PD Dr. med. Carsten Lennerz, Department of Electrophysiology, German Heart Centre Munich, Munich, Germany.

The results of the study should reassure patients with pacemakers/defibrillators that the tested cars are safe for them. PD Dr. med. Lennerz cautioned, however, that while these results as encouraging, rare events may still occur, and the technologies used are rapidly changing.

###

NOTES FOR EDITORS
Full openly available study: “Patients with pacemakers or defibrillators do not need to worry about e-Cars: An observational study,” by Carsten Lennerz, Lorenz Horlbeck , Severin Weigand, Christian Grebmer, Patrick Blazek, Amir Brkic , Verena Semmler, Bernhard Haller, Tilko Reents, Gabriele Hessling, Isabel Deisenhofer, Markus Lienkamp, Christof Kolb, and Matthew O’Connor (DOI: 10.3233/THC-191891), published in the Technology and Health Care, Volume 28, Issue 1 (2020) by IOS Press. The article is openly available at https://content.iospress.com/articles/technology-and-health-care/thc191891.

Contact Diana Murray, IOS Press, +1 718-640-5678, d.murray@iospress.com for additional information.

Journalists who wish to interview the authors should contact PD Dr. med. Lennerz at lennerz@dhm.mhn.de.

The primary findings of this study were previously published in a brief report in the Annals of Internal Medicine, but details about the methods and devices used are first being reported in this Technology and Health Care article.

ABOUT TECHNOLOGY AND HEALTH CARE
Technology and Health Care (THC) serves as a forum for the presentation of original articles and technical notes that observe rigorous scientific standards. The main focus of THC is related to the overlapping areas of engineering and medicine. Research articles focus on new concepts, procedures and devices associated with the use of technology in medical research and clinical practice for a readership with a widespread background in engineering and/or medicine. In particular, the clinical benefit deriving from the application of engineering methods and devices in clinical medicine are demonstrated. iospress.com/technology-and-health-care

ABOUT IOS PRESS
IOS Press is headquartered in Amsterdam with satellite offices in the USA, Germany, India and China and serves the information needs of scientific and medical communities worldwide. IOS Press now publishes more than 80 international peer-reviewed journals and about 75 book titles each year on subjects ranging from computer science, artificial intelligence, and engineering to medicine, neuroscience, and cancer research. iospress.com